コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
2 s Permeable contact lenses (RGP CL's) and 20 age-matched controls, using a HOA-based through-focus an
4 length/height, and body mass index during 5 age periods (conception to birth, birth to age 3 months,
5 ,000 person-years: age 18 to 24 years, 0.64; age 25 to 30 years, 0.65; men, 1.04; women, 0.36; Blacks
6 Norwegian risk factor profile, the absolute age-standardized CVD mortality gap would decline by 33.3
9 ith a metacognitive account, children across ages offloaded more often when the task was more difficu
11 l caseload of diabetic retinopathy in adults age 40 and older is expected to increase by 150% between
12 24-59 months, and 1.90 (1.53-2.31) in adults aged 55 years and older, 5 years after PCV10 introductio
13 ICIPANTS: Representative sample of US adults aged at least 40 years in the National Health and Nutrit
15 -label, randomised controlled trial, adults (aged 16-55 years) with symptomatic primary spontaneous p
17 Disease onset in females occurred across all age groups, without any comparable dramatic peak of onse
20 Thus, the P. falciparum reservoir in all ages can contribute to the maintenance and spread of ant
22 oth the selection coefficient and the allele age, to a one-dimensional search over the selection coef
24 mong 4847 adults of white European ancestry, aged 45 through 79 years, participating in the Atheroscl
27 was significantly related to height, BMI and age, and that there was an acceleration in muscle volume
29 adjustment for differences in CD4 counts and age, hrHPV prevalences were more similar over time: 32.6
37 s 3-12 months, ages 12 months-6.5 years, and ages 6.5-11.5 years) with fasting glucose, insulin, insu
42 iated with the level of cognitive ability at age-70 baseline (range of standardized beta-values = -0.
46 ort of women diagnosed with breast cancer at age <= 40 years and enrolled patients between 2006 and 2
51 Cervical screening involved HPV testing at age 35 years, or at ages 35 years and 45 years, with sca
53 involved HPV testing at age 35 years, or at ages 35 years and 45 years, with scale-up to 45% coverag
55 mination thresholds examined were an average age-standardised cervical cancer incidence of four or fe
56 blood samples from 185 young women (average age 21.2) in two cohorts and tested the effects of OC on
57 y infants, stools serially collected between ages 1-2 and 9-12 months were tested for non-toxigenic a
58 ildren's anxiety-depression symptoms between ages 3 to 8 years (adjusted odds ratio, 0.73; 95% confid
61 rvey data to describe testosterone levels by age in youths aged 6 to 20 years and the onset and magni
63 omised trial, patients with advanced cancer, aged at least 18 years, admitted to the palliative and s
66 ys), post-neonatal (age 28-364 days), child (age 1-4 years), and under-5 mortality rates (U5MRs) for
68 RotaTeq vaccine effectiveness among children aged 12-23 months was 84% (79-89) in low-mortality count
69 than 2 months, 0.86 (0.74-1.00) for children aged 2-23 months, 0.74 (0.62-0.87) for children aged 24-
70 d 2-23 months, 0.74 (0.62-0.87) for children aged 24-59 months, and 1.90 (1.53-2.31) in adults aged 5
71 nia was 0.92 (95% CI 0.70-1.36) for children aged younger than 2 months, 0.86 (0.74-1.00) for childre
72 as 9.8% (95% CI: 2.9%-19.8%) and in children aged <1 year old was 11.3% (95% CI: 4.4%-20.7%), while n
74 ses both stunting and overweight in children aged 4 years and older by providing school meals with im
76 different representative samples of children aged 6-29 months and their mothers were surveyed in each
80 romising intervention strategy for combating age-related cognitive decline in otherwise healthy indiv
81 RC in 50-year-old men and women (most common age of first screening), which were 0.44% and 0.41%, res
87 for the same individuals allow disentangling age patterns from idiosyncratic variation and analyzing
91 nt with severe disease at a relatively early age and most (67%) have slow-to-moderate progression of
92 g and, independently, of retinal environment age on their GABA(A) receptor (GABA(A)R) responses, elic
94 -controlled case-series method, we estimated age-adjusted incidence rate ratios within 1-7, 8-21, and
96 ording to streptococcal species adjusted for age, sex, >=3 positive blood culture bottles, native val
98 erm all-cause mortality after adjustment for age and sex, driven by early and noncardiovascular death
99 ted odds ratios (aORs) after controlling for age, race, and sex in multivariate analysis (asthma aOR
102 lls (HSCs) are thought to be responsible for age-related changes in haematopoiesis that include a dec
104 enrolled 1.5-45 year-olds (N=148) into four age-descending groups, randomized 2:1 to receive two dos
106 Women with small or large for gestational age offspring are at increased risk of cardiovascular di
108 h a decreased risk for small-for-gestational-age (aOR = 0.622, 95% CI 0.458-0.848, P = 0.002), and th
109 an increased risk for small-for-gestational-age (aOR = 1.955, 95% CI 1.465-2.578, P < 0.001; aOR = 1
111 se taking metformin were less likely to have age-related macular degeneration compared with those not
112 ding non-ST elevation MI, along with healthy age-matched subjects, were collected to assess chemokine
114 m sample was assessed for eligibility (HIV+, age >= 14 years, on ART >6 months, not acutely ill, CD4
115 om idiosyncratic variation and analyzing how age patterns change over time and across birth cohorts.
118 rystallised monazite yields a precise impact age of 2229 +/- 5 Ma, coeval with shock-reset zircon.
119 Patients managed with CCY did not differ in age, insurance, income, Charlson Comorbidity Index, diab
123 suggesting that the poor stroke recovery in aged mice can be reversed via poststroke bacteriotherapy
124 eurobiological bases of cognitive decline in aging populations may provide critical insights into the
126 lucanase action, respectively, and peaked in aging, strengthening tissues: CXE in xylem and cells bor
130 r life reflects both influences of intrinsic aging and those of lifestyle, environment and disease.
134 during pregnancy is rising as older maternal age, obesity, diabetes mellitus and hypertension become
139 c details for study participants were a mean age of 43.80 years, 47% male and 53% female, 38.5% with
140 ds: Ten patients with a peripheral AVM (mean age, 40 y; 4 men and 6 women) and scheduled for endovasc
141 atients studied at 2 weeks post-injury (mean age 52.8 years, range 22-77; 63 females; 64 right hemisp
146 ajor hepatic resection were randomized (mean age = 62.8 years; 57% male; body-mass-index = 27.9).
148 uding 4949 patients who underwent TAVR (mean age, 81+/-8 years, mean Society of Thoracic Surgeons sco
152 2 eyes of 47 patients (31 females) with mean age of 48.0 +/- 18.0 years and mean follow-up of 78.6 +/
155 total of 480,940 middle-aged adults (median age of 58 years [range 38-73], 46% male, 95% white) were
156 ts hospitalized for RV bronchiolitis (median age, 4 months), we identified 4 distinct endotypes-mainl
157 In sum, 23 227 patients (58% female; median age 34 years [interquartile range 28-41]) were ART-eligi
164 Sexually active unvaccinated women and men aged 16 to 25 years old were recruited from 119 public p
165 s and mechanisms that underlie microvascular aging, the greatest risk factor for cerebrovascular dise
166 H) and elevated cardiac biomarkers in middle age are at high risk for the development of heart failur
168 thin demyelination model in young and middle-aged mice, the latter group developed greater acute axon
170 th, birth to age 3 months, ages 3-12 months, ages 12 months-6.5 years, and ages 6.5-11.5 years) with
171 (conception to birth, birth to age 3 months, ages 3-12 months, ages 12 months-6.5 years, and ages 6.5
172 tions, and obesity were risk factors in most age-groups, with highest relative risks among 20-39 year
175 ted neonatal (age 0-27 days), post-neonatal (age 28-364 days), child (age 1-4 years), and under-5 mor
176 ltiple sclerosis (MS) attributable to normal aging increased from 42.7% and 16.7% respectively at age
179 tical analyses to characterize the impact of age on the overall changes in the systemic inflammation
180 A separate group of 15.5 to 17 months of age C57BL/6 mice received a diet containing an Nrf2 indu
182 ildren who initiated ART after 2.3 months of age, one of whom had two identical intact sequences, sug
183 eveals variability and a normal mean rate of age-related decline, consistent with largely nonprogress
184 HTRA1) are associated with increased risk of age-related macular degeneration (AMD) and disease progr
186 stics of drusen and other lesions typical of age-related maculopathy were determined by grading stere
189 years of age over horizons up to 8 years of age (area under the receiver operating characteristic cu
190 study in Iceland, children under 10 years of age and females had a lower incidence of SARS-CoV-2 infe
191 ally improves T1D prediction at >=2 years of age over horizons up to 8 years of age (area under the r
192 ded trial, 444 adults 60 through 64 years of age were randomized to receive either a single dose of P
194 days from symptom onset [DSO], >=18 years of age) were utilized to compare Veritor with the Lyra SARS
195 ia per patient, including 60.7% >75 years of age, 34.1% on anticoagulants, and 14.7% with renal failu
196 hy individuals who are less than 50 years of age, affecting probably no more than 1 in 1,000 such inf
197 perienced no cardiac events until 4 years of age, at which point she was hospitalized because of thre
202 yonic retinal progenitors for the effects of aging and, independently, of retinal environment age on
204 callosum exhibits substantial atrophy in old age, which is stronger than what would be predicted from
207 90 mL/min/1.73 m2 included white race, older age, higher body mass index, high-income region of enrol
208 nce showed a probable association with older age; elevated C-reactive protein (CRP), D-dimer, and fib
210 d consistent benefits for subgroups based on age, sex, diabetes, treatment with an ARNI and baseline
213 ly associated with 90-day mortality were: P: age, gender and ACLF type; I: drug, infection, surgery,
214 atures of the first VF: (1) base parameters (age, mean deviation, pattern standard deviation, glaucom
216 r dementia, analyzing data from participants aged 40 years or older in the National Health Insurance
218 However, modeling healthy and pathological aging of the human vasculature represents an unresolved
220 reoperative MRI examinations (median patient age, 56 years; range, 25-94 years), resulting in a posit
221 rse managers were excluded) and 829 patients aged 18 years or older, able to read and write Italian a
222 etrospective study of 3120 diabetic patients aged >= 60 years, those taking metformin were less likel
223 adding oseltamivir to usual care in patients aged 1 year and older presenting with influenza-like ill
224 rials.gov identifier: NCT02953678), patients aged at least 12 years with grades II to IV steroid-refr
227 ry Network (NSPN), a cohort of young people (aged 18-29 years) in the United Kingdom, who provided qu
228 d high interest in genetic testing as a PLD: age >=35 years (adjusted odds ratio [aOR], 1.75; 95% con
229 77 US cities and for the Medicare population aged 65 years and older across 3,113 US counties, respec
230 es in the memory Th17 compartment predispose aged mice toward the development of severe corneal epith
232 and either no neuritic plaques (i.e. primary age-related tauopathy) or moderate to frequent neuritic
237 found between the two study groups regarding age at first IAC injection, disease grouping at diagnosi
238 34 had perinatal HIV infection, and reported age at sexual debut and history of heterosexual vaginal
241 recurrent respiratory infections, revealing age-dependent variation and suggesting a role for IgG gl
243 estimated that vaccinating 50%-70% of school-aged children for influenza can produce population-wide
244 ncreasing among young adults below screening age, despite the effectiveness of screening in older pop
246 Of 197 hospitalized patients, the mean (SD) age of the cohort was 60.6 (16.2) years, 103 (52.3%) wer
247 nts included in this analysis, the mean (SD) age was 48 (19) years and 25 939 (50.1%) were women; 43.
248 Among the 13 078 treated patients (mean [SD] age, 62.5 [9.0] years; 35% women; 70% with diabetes; med
250 potential confounders at patient level (sex, age) and practice level (list size, locality, pre-interv
252 IFICANCE STATEMENT Prior work suggested that age-related CA3 hyperactivity enhances pattern completio
258 y lower than that of non-carriers, while the age at onset of carriers with other gene pathogenic/like
260 tein damage, which is substantial during the aging of short-lived mice, is stabilized at low levels d
261 To address the challenges unique to this age group, novel strategies to provide the best preopera
262 second TC incidence was also lower for those age >= 30 years (2.8%; 95% CI, 2.3 to 3.4) at first TC d
265 5 age periods (conception to birth, birth to age 3 months, ages 3-12 months, ages 12 months-6.5 years
270 , active choroidal neovascularization due to age-related macular degeneration in the study eye were r
271 rate of death was inversely proportional to age, such that frailty had a stronger adverse impact on
272 nts were 55 to 90 years with GA secondary to age-related macular degeneration (AMD) and best-correcte
273 (SIS) transmission models simultaneously to age-stratified vivax malaria incidence densities and the
276 Despite their relevance for understanding aging and cancer, the processes that underpin mutational
278 methyl-2,4-nonanedione (MND) during red wine aging can contribute to the premature evolution of aroma
279 yloidogenic processing of APP, combined with age-dependent iron elevation in the tissue, increases pr
281 c aneurysm or dissection, in comparison with age- and sex-matched controls (1:10 for aortic aneurysm
283 gh the size of the BK current decreased with age, IHCs retained a normal KCNQ4 current and resting me
290 vealed that the failure of proteostasis with age is triggered by developmental and reproductive cues
292 om a secondary data analysis for 1,022 women aged 15-24 who reported ever having sex: 326 adolescents
295 racially/ethnically diverse pregnant women (aged 20-45 years-33% primiparous, 37% biparous, 30% mult
297 ups (e.g., CVD rates per 1,000 person-years: age 18 to 24 years, 0.64; age 25 to 30 years, 0.65; men,
298 monthly ranibizumab treatments were younger age (P < 0.0001) and worse baseline BCVA (P < 0.0001).
299 is estimated that every day about 1600 youth aged 12 to 17 years smoke their first cigarette and that
300 escribe testosterone levels by age in youths aged 6 to 20 years and the onset and magnitude of diverg